Medicine Guideline of Phospholipids Survanta Intratracheal 8 ml Injection

Phospholipids Survanta Intratracheal 8 ml Injection contains beractant, a aspiratory surfactant, which is a common bovine lung extricate containing phospholipids, unbiased lipids, greasy acids, and surfactant-associated proteins (SP) to which colfosceril palmitate (dipalmitoyl phosphatidylcholine), palmitic corrosive, and tripalmitin are included to standardize the composition and to mirror surface-tension bringing down properties of characteristic lung surfactant.

This Medicine contains about composition gives 25 mg/mL of phospholipids (counting 11.0-15.5 mg/mL of disaturated phosphatidylcholine), 0.5-1.75 mg/mL of triglycerides, 1.4-3.5 mg/mL of free greasy acids, and less than 1 mg/mL of SP (counting SP-B, a 79-amino corrosive protein, and SP-C, a 35-amino corrosive peptide).

Phospholipids Survanta Intratracheal 8 ml Injection is a sterile, preservative-free, non-pyrogenic off-white to light brown fluid provided in single-dose glass vials for intratracheal utilize as it were. Each vial contains 4 mL (100 mg phospholipids) or 8 mL (200 mg phospholipids).

Each mL of SURVANTA contains 25 mg of phospholipids. It is suspended in 0.9% sodium chloride arrangement and heat-sterilized. SURVANTA contains no additives. Sodium hydroxide or hydrochloric corrosive may be included to alter the pH. The pH is around 6.2 to 7.6.